Slawin KM - Search Results

1

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.

Shariat SF, Kim JH, Andrews B, Kattan MW, Wheeler TM, Kim IY, Lerner SP, Slawin KM. Shariat SF, et al. Among authors: slawin km. Cancer. 2001 Dec 15;92(12):2985-92. doi: 10.1002/1097-0142(20011215)92:12<2985::aid-cncr10175>3.0.co;2-5. Cancer. 2001. PMID: 11753975

2

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.

Shariat SF, Monoski MA, Andrews B, Wheeler TM, Lerner SP, Slawin KM. Shariat SF, et al. Among authors: slawin km. Urology. 2003 May;61(5):1053-8. doi: 10.1016/s0090-4295(02)02522-0. Urology. 2003. PMID: 12736046

3

Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.

Shariat SF, Roudier MP, Wilcox GE, Kattan MW, Scardino PT, Vessella RL, Erdamar S, Nguyen C, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: slawin km. Cancer Res. 2003 Aug 1;63(15):4662-70. Cancer Res. 2003. PMID: 12907647

4

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

Kattan MW, Shariat SF, Andrews B, Zhu K, Canto E, Matsumoto K, Muramoto M, Scardino PT, Ohori M, Wheeler TM, Slawin KM. Kattan MW, et al. Among authors: slawin km. J Clin Oncol. 2003 Oct 1;21(19):3573-9. doi: 10.1200/JCO.2003.12.037. Epub 2003 Aug 11. J Clin Oncol. 2003. PMID: 12913106 Clinical Trial.

5

Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.

Shariat SF, Kattan MW, Song W, Bernard D, Gottenger E, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: slawin km. Cancer Res. 2003 Sep 15;63(18):5874-8. Cancer Res. 2003. PMID: 14522912

6

Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.

Matsumoto K, Shariat SF, Casella R, Wheeler TM, Slawin KM, Lerner SP. Matsumoto K, et al. Among authors: slawin km. J Urol. 2003 Dec;170(6 Pt 1):2248-52. doi: 10.1097/01.ju.0000094189.93805.17. J Urol. 2003. PMID: 14634390

7

Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.

Shariat SF, Kattan MW, Traxel E, Andrews B, Zhu K, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: slawin km. Clin Cancer Res. 2004 Mar 15;10(6):1992-9. doi: 10.1158/1078-0432.ccr-0768-03. Clin Cancer Res. 2004. PMID: 15041717

8

Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.

Shariat SF, Anwuri VA, Lamb DJ, Shah NV, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: slawin km. J Clin Oncol. 2004 May 1;22(9):1655-63. doi: 10.1200/JCO.2004.09.142. J Clin Oncol. 2004. PMID: 15117988 Clinical Trial.

9

Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.

Shariat SF, Menesses-Diaz A, Kim IY, Muramoto M, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: slawin km. Urology. 2004 Jun;63(6):1191-7. doi: 10.1016/j.urology.2003.12.015. Urology. 2004. PMID: 15183988

10

Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.

Shariat SF, Lamb DJ, Kattan MW, Nguyen C, Kim J, Beck J, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: slawin km. J Clin Oncol. 2002 Feb 1;20(3):833-41. doi: 10.1200/JCO.2002.20.3.833. J Clin Oncol. 2002. PMID: 11821468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters